Don't want ads? Subscribe or login now.

AbbVie Faces 2nd Investor Suit Over Humira Kickbacks

By Diana Novak Jones · October 10, 2018, 3:09 PM EDT

AbbVie Inc. was hit with another proposed class action over its allegedly illegal strategy to market its blockbuster drug Humira, this one filed Tuesday by shareholders in Illinois federal court who...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Holwill v. AbbVie Inc. et al

Case Number

1:18-cv-06790

Court

Illinois Northern

Nature of Suit

850 Securities/Commodities

Date Filed

October 09, 2018

Recent Articles By Diana

July 01, 2021
Fla. Employer Doesn't Have To Pay For Medical Pot Evaluation
June 30, 2021
As Medical Pot Sales Begin, SD Gov. Releases Cops' Policy
June 30, 2021
Pot Software Co. Says Contract Suit Counterclaims Too Thin
June 28, 2021
Detroit Will Face Trial In Suit Over Medical Pot Raid
June 18, 2021
Mass. Pot Regulators Hit TILT, Ayr With Nearly $600K In Fines
June 17, 2021
Detroit Pot Licensing Scheme 'Likely Unconstitutional'
June 10, 2021
9th Circ. Skeptical Of Researcher's Shot At DEA Pot Rule
June 07, 2021
Justices Won't Hear Challenge To FDA Regulation Of E-Cigs
June 04, 2021
Okla. Medical Pot Rule Challenge Ends Over Pot's Illegality
June 04, 2021
Fla. High Court Keeps Tight Grip On Medical Pot Licenses